TrialAnnals of the rheumatic diseases2006

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.

M E Weinblatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.